Mon.Aug 26, 2024

article thumbnail

Pharmacogenomics: The Up-and-Coming Field of Pharmacy

Pharmacy Is Right For Me

What is your first thought when you think of a career in pharmacy? You may think of a clinical pharmacist working in a community pharmacy or a hospital pharmacist working in an in-patient unit. But did you think about pharmacogenomics: the field of pharmacy that studies how someone’s genetics affect their response to a certain drug? Not many people are aware of the field of pharmacogenomics, and how it can optimize patient outcomes.

article thumbnail

High-Dose, Adjuvanted Flu Vaccines Prove More Effective for Older Adults

Drug Topics

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Vaccines 168
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Tafasitamab, Lenalidomide Combination Modestly Effective in Patients With Large B-Cell Lymphoma

Pharmacy Times

Aligning with previous data, the drug combination was modestly effective in patients with large B-cell lymphoma pre- and post-CAR-T-cell therapy.

154
154
article thumbnail

Dexcom’s OTC Continuous Glucose Monitor Now Available in US

Drug Topics

The Stelo glucose biosensor system is intended for use in adults who do not use insulin or in those without diabetes who wish to better understand how diet and exercise affect blood glucose levels.

154
154
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times

STAT

Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard and my own institution, Penn. Besides struggling with encampments, building takeovers, and commencement challenges, the three universities have something else in common: They have all chosen M.D.s as president or interim president.

145
145
article thumbnail

Fish Oil Supplementation May Reduce Genetic Risk of High Cholesterol

Pharmacy Times

Pharmacists can be essential sources of education for patients, offering them guidance on safe use and proper dosage.

Dosage 144

More Trending

article thumbnail

Recent moves by Epic, Carequality mark a major shift in interoperability, health IT experts say

Fierce Healthcare

Electronic health records giant Epic recently announced plans to transition its customers to a new government-backed data exchange by the end of next year. | Carequality and Epic both revealed plans to align with TEFCA, signaling potentially a "tectonic shift" in the interoperability landscape and the rising influence of the federal government's nascent network, health IT experts say.

134
134
article thumbnail

Opinion: Who should get to see the neurologist first: the sick or the at-risk?

STAT

Once a year, Jessi Keavney goes to see her neurologist. During the visit, the doctor asks if she has developed any new symptoms and then performs a detailed physical exam. He observes the speed and amplitude of her hand and foot movements, and then assesses her ability to stand from a seated position. While she walks, the doctor evaluates her arm swing, the length of her stride, and her posture.

138
138
article thumbnail

HRSA, hospitals say J&J's plan for 340B discounts via rebate not supported by statute

Fierce Healthcare

A major drugmaker’s plan to trade out upfront 340B discounts for rebates has found swift pushback from both hospitals participating in the drug subsidy program and the government administration tha | The drugmaker said it plans to require DSH covered entities obtain their drug discounts by submitting for a rebate after dispensing. That approach would add financial and liquidity strain to safety-net hospitals and goes against 340B statute, per a hospital industry group statement that was echoed b

Hospitals 128
article thumbnail

WHO launches plan to stanch mpox transmission and says the virus can be stopped

STAT

The U.N. health agency on Monday launched a six-month plan to help stanch outbreaks of mpox transmission, including ramping up staffing in affected countries and boosting surveillance, prevention and response strategies. The World Health Organization said it expects the plan from September through February next year will require $135 million in funding and aims to improve fair access to vaccines, notably in African countries hardest hit by the outbreak.

Vaccines 127
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Waltz Health debuts specialty pharmacy platform, partners with Reliance Rx to slash drug costs

Fierce Healthcare

A new specialty pharmacy program by digital health company Waltz Health has been created to lower costs for payers and provide better experiences for patients and pharmacies. | Waltz Connect will use its AI engine to route specialty drug prescriptions to the most ideal location for payers and patients based on weighted attributes. The company is also partnering with Reliance Rx.

article thumbnail

A Galapagos investor signals impatience with its turnaround efforts

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. And hello again! Miss us?

123
123
article thumbnail

ICYMI: Total Pharmacy August 2024 Issue

Drug Topics

Don’t miss out on the latest pharmacy insights in the Total Pharmacy June issue.

123
123
article thumbnail

J&J's attempt to tweak 340B policy for Stelara, Xarelto denounced by HHS

Fierce Pharma

Even as Johnson & Johnson prepares to weather the impact of negotiated Medicare drug prices on two of its | The new rebate model would require eligible hospitals to submit rebate claims after paying full price for the drugs, as opposed to upfront discounts.

Hospitals 119
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

J&J's bid to change pay model for Stelara, Xarelto slammed

pharmaphorum

A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals in the controversial 340B programme

Hospitals 119
article thumbnail

UCB sells off production plant and a clutch of older meds in China for $680M

Fierce Pharma

Restructuring seems to be the name of the game for many large drugmakers these days, and Belgium-based UCB is no except | Belgium’s UCB is selling off its mature neurology and allergy business—plus a manufacturing plant—in mainland China. The deal will see local healthcare asset manager CBC Group and Abu Dhabi-based investment firm Mubadala pay UCB $680 million.

119
119
article thumbnail

A virus bodega, DNC takeaways, and free Covid tests

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Happy Eldest Daughter Day. I am not the first daughter in my family, but I was always the oldest sibling in the house while growing up. I’m often willing to indulge in a discussion of that burden, but I saw the movie “Dìdi” this weekend.

115
115
article thumbnail

After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab

Fierce Pharma

Five months after the FDA rejected Regeneron’s bid for acc | Five months after the FDA rejected Regeneron’s bid for accelerated approval of its T-cell engager odronextamab because of the immaturity of its confirmatory trial, the European Union has signed off on the treatment for two types of blood cancers. The European Commission also approved SIFI's first-of-its-kind Akantior for a rare corneal infection disorder.

FDA 114
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Aetna to roll out expanded fertility benefits nationwide

Fierce Healthcare

Aetna will now cover intrauterine insemination (IUI) as a benefit in eligible plans nationwide, becoming the first major insurer to expand coverage nationally. | Aetna will now cover intrauterine insemination as a benefit in eligible plans nationwide, becoming the first major insurer to expand coverage nationally.

Insurance 111
article thumbnail

With new focus, Kyowa Kirin pulls decades-old breast cancer drug Fareston from US market

Fierce Pharma

Breast cancer treatments have evolved dramatically over the years, so Kyowa Kirin has decided to stop selling a decades-old drug in the U.S. | Breast cancer treatments have evolved dramatically over the years, so Kyowa Kirin has decided to stop selling a decades-old drug in the U.S.

111
111
article thumbnail

STAT+: Pharmalittle: UCB selling a Chinese business, Tome layoffs, and more

STAT

Happy Monday, Pharmalittle family. Adam Feuerstein here, once again filling in for Ed. I have been assured that Ed is staying caffeinated, even in his absence. Let’s take a look at some morning news. … Belgian drugmaker UCB is selling its Chinese neurology and allergy business to Singapore-based asset management group CBC and Abu Dhabi sovereign investor Mubadala for $680 million , Reuters tells us.

article thumbnail

The Coalition for Health AI wants local governance and national standards for health AI

Fierce Healthcare

In this week's episode of "Podnosis," we dive into a discussion with two founders of the | In this week's episode of "Podnosis," we dive into a discussion with two founders of the Coalition for Health AI about why both local providers and the federal government must play a role in overseeing AI in healthcare.

108
108
article thumbnail

Individuals Born in Autumn or Winter More Likely to Develop Asthma, Allergic Rhinitis

Pharmacy Times

In Finland, season of birth, notably autumn and winter, was associated with the development of asthma and allergic rhinitis.

107
107
article thumbnail

Does gabapentin cause weight gain?

The Checkup by Singlecare

Gabapentin (brand name Neurontin ) is an anti-seizure medication that is primarily used to alleviate nerve pain and manage seizures. The prescription drug is FDA approved to control seizures in adults and children with epilepsy and treat a type of nerve pain called postherpetic neuralgia (PHN) that can occur after a shingles infection. It’s also used off-label to treat diabetic neuropathy, fibromyalgia, neuropathic pain from sciatica, alcohol dependence, and anxiety.

Dosage 105
article thumbnail

Cigna's Express Scripts to cross out AbbVie's Humira from some formularies in 2025, opting to go with biosims instead

Fierce Pharma

When CVS Caremark removed AbbVie’s Humira from its national commercial formularies back in April, biosimilar prescriptions picked up at a whirlwind pace. | Following CVS Caremark's lead, Cigna's pharmacy benefit manager unit will nix Humira from formularies in favor of Humira biosimilars from Boehringer Ingelheim, Teva and Sandoz.

105
105
article thumbnail

DEA To Announce Hearing on Proposed Marijuana Rescheduling

The FDA Law Blog

By Larry K. Houck — Who says nothing happens in Washington, D.C., in August? The Drug Enforcement Administration (“DEA”) will announce Thursday in the Federal Register that it will hold a hearing on the proposed rescheduling of marijuana to schedule III at DEA Headquarters in Arlington, Virginia on December 2, 2024. DEA received over 43,500 public comments in response to the agency’s Notice of Proposed Rulemaking in the Federal Register on May 21, 2024.

article thumbnail

Apremilast Now Available to Treat Pediatrics With Plaque Psoriasis

Pharmacy Times

Pediatric patients weighing 20 kg to <50 kg should take 20 mg of apremilast twice daily and children weighing at least 50 kg should take 30 mg twice daily.

101
101
article thumbnail

Changing Faces – Agency, consultancy, and investor hires from July 2024

pharmaphorum

Changing Faces – Agency, consultancy, and investor hires from July 2024: Stay updated on the latest hires at EVERSANA, Ogilvy Health, Skarbek, and more in the industry.

98
article thumbnail

FDA Grants Fast Track Designation to 64Cu-SAR-bisPSMA for Prostate Cancer Diagnosis

Pharmacy Times

The proposed diagnostic agent has a long half-life, enables imaging the next day, and correlates to a longer shelf life in the pharmacy.

FDA 94
article thumbnail

Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment

pharmaphorum

Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment Mike.

FDA 97
article thumbnail

Five Years Later: The Case for a COVID-19 Memorial Day

Pharmacy Times

Let’s shine the spotlight on ourselves, and let’s begin to heal.

94
article thumbnail

Omnipod 5 FDA Cleared for Use in Adults With Type 2 Diabetes

Drug Topics

The device was previously cleared for use in children and adults with type 1 diabetes.

FDA 86
article thumbnail

Technicians Prepare for Growing Roles in Immunizations

Pharmacy Times

Building trust between techs and patients makes administering vaccines easier and increase immunizers’ confidence.